| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/10/1994 | EP0609217A1 Dry starch-iodine pharmaceutical formulations |
| 08/10/1994 | CN1090509A Pharmaceutical composition |
| 08/10/1994 | CN1090508A Physiologically active peptide composition |
| 08/10/1994 | CN1025591C Method for production of vaginal suppositories |
| 08/09/1994 | US5336767 Total or partial esters of hyaluronic acid |
| 08/09/1994 | US5336760 Method and useful apparatus for preparing pharmaceutical compositions |
| 08/09/1994 | US5336692 High-molecular-weight petrolatum, solvent and a compound both hydrophobic and hydrophilic; protective coatings for skin; moisturizers; spreadability; long-lasting |
| 08/09/1994 | US5336669 Mixture with hydrate which has been melted, precipitated, refrozen and redried, crystal structure, water solubility |
| 08/09/1994 | US5336668 Esters of alginic acid |
| 08/09/1994 | US5336603 CD4 adheson variants |
| 08/09/1994 | US5336508 Sodium silver chloride |
| 08/09/1994 | US5336507 Use of charged phospholipids to reduce nanoparticle aggregation |
| 08/09/1994 | US5336506 Targeting of therapeutic agents using polysaccharides |
| 08/09/1994 | US5336505 Bioerodible polymers useful for the controlled release of therapeutic agents |
| 08/09/1994 | US5336499 Molecular crystal device for pharmaceuticals |
| 08/09/1994 | US5336493 Superoxide dismutase-catalase conjugates |
| 08/09/1994 | US5336484 Compositions of iodophenyl esters and iodophenyl sulfonates in film-forming materials for visualization of the gastronintestinal tract |
| 08/09/1994 | US5336264 Situ prepared calcium phosphate composition and method |
| 08/09/1994 | CA1331344C Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates |
| 08/09/1994 | CA1331341C Covered retard forms |
| 08/09/1994 | CA1331338C Aqueous film-forming compositions for controlling the release of active agents and process of making same |
| 08/04/1994 | WO1994017125A1 Structured copolymers used as absorbents, gels and carriers of metal ions |
| 08/04/1994 | WO1994017039A1 Cyclic imide thione activated polyalkylene oxides |
| 08/04/1994 | WO1994016991A1 Stable sulfide compositions, uses, and process for preparation thereof |
| 08/04/1994 | WO1994016735A1 Anti-zona pellucida antibodies for delivery of therapeutic agents to the ovary |
| 08/04/1994 | WO1994016734A1 Amplified direction of effector groups to specific target cells in an animal |
| 08/04/1994 | WO1994016733A1 Highly soluble multicomponent inclusion complexes containing a base type drug, an acid and a cyclodextrin |
| 08/04/1994 | WO1994016731A1 Ganglioside-klh conjugate vaccines with qs-21 |
| 08/04/1994 | WO1994016729A1 Targeted nitric oxide pathway or nitric oxide synthase modulation |
| 08/04/1994 | WO1994016720A1 COMPOSITIONS CONTAINING TRANSFORMING GROWTH FACTOR β STABILIZED BY GLYCOSAMINOGLYCANS |
| 08/04/1994 | WO1994016706A1 Therapeutic inhibitors of vascular smooth muscle cells |
| 08/04/1994 | WO1994016699A1 Compositions containing tandospirone or its analogs |
| 08/04/1994 | WO1994016695A1 Pharmaceutical compositions containing cimetidine |
| 08/04/1994 | WO1994016693A1 Stable oral ci-981 formulation and process of preparing same |
| 08/04/1994 | WO1994016683A1 Magnetically responsive composition for carrying biologically active substances and methods of production and use |
| 08/04/1994 | WO1994016682A1 Novel, percutaneously absorbable preparation |
| 08/04/1994 | WO1994016681A1 Recombinant living subunit vaccine composition and process for its preparation |
| 08/04/1994 | WO1993025583A3 Proteinoid carriers and methods for preparation and use thereof |
| 08/04/1994 | CA2154902A1 Recombinant living subunit vaccine composition and process for its preparation |
| 08/04/1994 | CA2154874A1 Highly soluble multicomponent inclusion complexes containing a base type drug, an acid and a cyclodextrin |
| 08/04/1994 | CA2154471A1 Amplified direction of effector groups to specific target cells in an animal |
| 08/04/1994 | CA2153882A1 Novel transdermal absorption preparation |
| 08/04/1994 | CA2152673A1 Compositions containing tandospirone or its analogs |
| 08/04/1994 | CA2132632A1 Anti-zona pellucida antibodies for delivery of therapeutic agents to the ovary |
| 08/03/1994 | EP0609042A1 Drug composition and process for preparing the same |
| 08/03/1994 | EP0608921A2 Modified polyester composition and preparation process and use thereof |
| 08/03/1994 | EP0608908A2 Dense star polymers and a process for producing dense star polymers |
| 08/03/1994 | EP0608831A1 Compositions containing argatroban analogs |
| 08/03/1994 | EP0608828A1 Compositions containing argatroban analogs |
| 08/03/1994 | EP0608433A1 Composition for dermatologic preparation |
| 08/03/1994 | EP0608362A1 Device for the transdermal administration of melatonin |
| 08/03/1994 | EP0608353A1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES. |
| 08/03/1994 | EP0608322A1 Enhanced skin penetration system for improved topical delivery of drugs |
| 08/03/1994 | EP0608320A1 Enhanced skin penetration system for improved topical delivery of drugs |
| 08/03/1994 | EP0608313A1 Formulations of blood clot-polymer matrix for delivery of osteogenic proteins |
| 08/03/1994 | EP0417154B1 Method upon a temperature increase of counteracting a viscosity decrease or providing a viscosity increase in a water-base system containing a polymer as viscosity agent |
| 08/03/1994 | EP0402407B1 Transdermal estradiol delivery system |
| 08/03/1994 | CN1090205A Preparation of aquogel with polyvinyl alcohol support and its products |
| 08/03/1994 | CN1090196A Liquid for curing bone fracture |
| 08/03/1994 | CN1090175A Fortifier which promotes growth of erythrocytes and prevents from anemia |
| 08/03/1994 | CN1090174A Stabilised hexadecylphosphocholine solutions in glycerol alkyl ethers |
| 08/03/1994 | CN1090171A Oral medicament form |
| 08/03/1994 | CN1090170A Novel composition based on taxoides derivative |
| 08/03/1994 | CN1090126A Quick-drying gel-type disinfectant for hands and fingers |
| 08/02/1994 | US5334761 Cationic lipids |
| 08/02/1994 | US5334713 N-long chain acyl neutral amino acid esters |
| 08/02/1994 | US5334711 Synthetic catalytic oligonucleotide structures |
| 08/02/1994 | US5334394 A core particle with a surface coatings consisting of maltose, cellobiose, trehalose, isomaltose, nystose, maltotriose and nitrocellulose, bonding with immobilized virus cells; aids vaccines |
| 08/02/1994 | US5334392 Hypotensive agents |
| 08/02/1994 | US5334391 Intracellularly cleavable compounds |
| 08/02/1994 | US5334382 Lyophilized polyethylene oxide modified catalase composition, polypeptide complexes with cyclodextrin and treatment of diseases with the catalase compositions |
| 08/02/1994 | US5334381 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
| 08/02/1994 | US5334379 Cytokine and hormone carriers for conjugate vaccines |
| 08/02/1994 | US5334378 Suspension consists of complex of ion exchange resin and active ingredient, thickening agent consists of natural gums, cellulose derivatives and alginates, amino acid or salt stabilizer and water |
| 08/02/1994 | US5334138 Drug delivery; mixture of active material and vasoconstrictor |
| 08/02/1994 | CA1331137C Transdermal flux enhancing compositions |
| 08/02/1994 | CA1331136C Stable mixture containing oxidation-sensitive compounds, preparation thereof and use of a combination of substances for stabilizing oxidation-sensitive compounds |
| 08/02/1994 | CA1331135C _-globulin injectable solutions |
| 08/02/1994 | CA1331133C Pharmaceutical growth hormone formulations |
| 08/02/1994 | CA1331131C Cyclic peptides as promoters of absorption on administration onto the mucosa |
| 07/28/1994 | DE4301801A1 Crosslinked N-vinyl]-imidazolium salt polymers |
| 07/27/1994 | EP0608207A1 Nanocapsule containing pharmaceutical compositions |
| 07/27/1994 | EP0607978A1 Phospholipid derivative and liposome containing it |
| 07/27/1994 | EP0607963A1 Crosslinked isocyanate-functional polymer supports |
| 07/27/1994 | EP0607467A1 Compositions containing S(+)-Ibuprofen |
| 07/27/1994 | EP0607434A1 Anti-inflammatory analgesic plaster |
| 07/27/1994 | EP0607332A1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 07/27/1994 | EP0607229A1 Pharmaceutical compositions comprising a calcitonin, a glycyrrhizinate as absorption enhancer and benzyl |
| 07/27/1994 | EP0607222A1 Dendrimeric polychelants |
| 07/27/1994 | EP0607206A1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 07/27/1994 | EP0607156A1 Process for producing preserved medicaments containing human proteins for the purposes of infusion or injection. |
| 07/27/1994 | EP0607126A1 Complex for in-vivo target localization |
| 07/27/1994 | EP0607118A1 A phospholipid delivery system |
| 07/27/1994 | EP0603303A4 Antimicrobial compositions containing propylene carbonate and/or ethylene carbonate as the carrier solvent. |
| 07/27/1994 | EP0576589A4 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 07/27/1994 | EP0414816B1 Induction of tolerance to a foreign antigen |
| 07/27/1994 | EP0399001B1 T-cell epitope as carriers molecule for conjugate vaccines |
| 07/27/1994 | EP0191771B1 Automatic injector assembly |
| 07/27/1994 | CN1089950A Derivatives of structurally modified vip and pharmaceutical compositions containing them |
| 07/27/1994 | CN1089837A Ophthalmological preparation |